Apixaban increases bleeding with no benefit in high-risk patients with ACS
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Apixaban Increases Bleeding With No Benefit in High-risk Patients With ACS." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS.
Apixaban increases bleeding with no benefit in high-risk patients with ACS. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS. Accessed August 31, 2024.
Apixaban increases bleeding with no benefit in high-risk patients with ACS. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS
Apixaban Increases Bleeding With No Benefit in High-risk Patients With ACS [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 August 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Apixaban increases bleeding with no benefit in high-risk patients with ACS
ID - 427359
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -